Viz AAA vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Viz AAA

by Viz.ai

iCAC Device

by Bunkerhill Health

AI Verdict

Viz AAA is designed for the rapid detection and triage of acute Abdominal Aortic Aneurysms from CT angiography scans, aiming to accelerate urgent care coordination. In contrast, Bunkerhill Health's iCAC Device focuses on opportunistically identifying and quantifying coronary artery calcium from routine chest CTs to aid in early cardiovascular disease detection and risk assessment. Therefore, they address distinct clinical needs within cardiovascular imaging.

Choose Viz AAA if…

Choose Viz AAA if your primary need is rapid, AI-powered detection and immediate triage of suspected Abdominal Aortic Aneurysm (AAA) from CTA scans. This tool is ideal for emergency departments and vascular surgery teams requiring real-time alerts and a coordinated communication platform to accelerate critical treatment decisions and improve acute patient outcomes.

View Viz AAA →

Choose iCAC Device if…

Choose iCAC Device if your goal is to opportunistically screen for and quantify coronary artery calcium (CAC) from routine, non-contrast chest CT scans to assess cardiovascular disease risk. This solution is well-suited for radiologists and cardiologists looking to leverage existing imaging data to provide adjunctive information for long-term patient management and proactive risk stratification.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Viz AAA	iCAC Device
Pricing	Enterprise (hospital/health system)	Contact for pricing
Deployment	Cloud-based, integrates with PACS and EHR systems.	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA offers a comprehensive user experience with features like integration into existing hospital workflows, real-time alerts, and a HIPAA-compliant communication platform. Its mobile access to high-fidelity imaging and patient information further enhances usability for multidisciplinary care teams, extending beyond just image interpretation.

Clinical Value

Viz AAA

Viz AAA addresses the critical and time-sensitive detection and triage of suspected Abdominal Aortic Aneurysm (AAA), directly impacting acute patient outcomes and care coordination. While iCAC Device provides valuable opportunistic screening for cardiovascular risk, Viz AAA's focus on an acute, life-threatening condition with a triage component offers a more immediate and direct clinical impact.

Pricing & Value

Tie

Both tools lack public pricing transparency, making a direct comparison of their value propositions difficult. Viz AAA indicates a subscription model based on algorithms and population size, but no specific tiers are available, and iCAC Device requires contacting the vendor for any pricing details.

Enterprise Readiness

Viz AAA

Viz AAA explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are crucial for enterprise adoption. As a product from Viz.ai, a company with a strong track record in large-scale hospital deployments, it demonstrates a higher level of proven enterprise readiness compared to Tool B, which requires contacting the vendor for these details.

Innovation

Viz AAA

Viz AAA is highlighted as the 'first FDA-cleared AI-powered solution' for the detection and *triage* of suspected AAA, indicating a pioneering role in a critical acute care pathway. While iCAC Device's opportunistic screening for CAC from routine scans is innovative, Viz AAA's focus on immediate detection and care coordination for a life-threatening condition represents a significant advancement in workflow transformation and acute intervention.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer specific details regarding the support services or documentation for either tool. Without this crucial information, it is not possible to definitively distinguish between the two offerings in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Viz AAA	iCAC Device
Name	Viz AAA	iCAC Device
Company	Viz.ai	Bunkerhill Health
Primary Detection Target	Suspected Abdominal Aortic Aneurysm (AAA)	Coronary Artery Calcium (CAC)
Input Scan Type	CT angiography scans	Routine, non-contrast, non-gated chest CT scans
Key Output/Analysis	AI-powered automatic detection of suspected AAA, automated triage and prioritization, real-time alerts, HIPAA-compliant communication platform	Estimates presence and quantity of CAC, visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units

Videos

Demos, reviews, and walkthroughs featuring Viz AAA and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific medical conditions do these AI tools help detect?

Viz AAA is designed for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. In contrast, the iCAC Device detects and quantifies coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.

What types of imaging scans are required for each tool's analysis?

Viz AAA analyzes CT angiography (CTA) scans to identify suspected AAA. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans for the presence and quantity of coronary artery calcium.

How do these tools integrate into clinical workflows and what information do they provide to care teams?

Viz AAA integrates into existing hospital workflows, providing automated triage, real-time alerts to care teams, and a HIPAA-compliant communication platform for multidisciplinary teams. The iCAC Device integrates with PACS or DICOM routers and EHRs via the Carebricks platform, providing adjunctive information to radiologists, including visual representation and quantitative estimates of CAC burden in Agatston units.

Which medical specialties are these AI tools primarily designed for?

Viz AAA is primarily designed for Emergency Medicine, Radiology, and Vascular Surgery specialties. The iCAC Device primarily serves Cardiology and Radiology specialties.

Beyond detection, what specific actionable insights or features do these tools offer to care teams?

Viz AAA is designed to accelerate diagnosis and care coordination through automated triage, prioritization of cases, and real-time alerts to care teams, including mobile access to imaging and patient information. The iCAC Device provides quantitative estimates of CAC burden in Agatston units and visual representations of estimated CAC segmentation, supporting opportunistic identification of CAC from existing CT scans and aiding in early cardiovascular disease detection.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Viz AAA or iCAC Device

Backers

Who funded each tool's parent company.

Viz AAA

Scale Venture Partners